Integrative modeling uncovers p21-driven drug resistance and prioritizes therapies for PIK3CA-mutant breast cancer.

Yip, Hon Yan Kelvin; Shin, Sung-Young; Chee, Annabel; Ang, Ching-Seng; Rossello, Fernando J; Wong, Lee Hwa; Nguyen, Lan K; Papa, Antonella

Yip, Hon Yan Kelvin; Shin, Sung-Young; Chee, Annabel; Ang, Ching-Seng; Rossello, Fernando J; Wong, Lee Hwa; Nguyen, Lan K; Papa, Antonella.

Afiliação

Yip HYK; Cancer Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, 3800, Australia.
Shin SY; Cancer Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, 3800, Australia.
Chee A; Cancer Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, 3800, Australia.
Ang CS; Centre for Muscle Research, Department of Anatomy and Physiology, The University of Melbourne, Melbourne, VIC, 3010, Australia.
Rossello FJ; Bio21 Mass Spectrometry and Proteomics Facility, The University of Melbourne, Parkville, VIC, 3010, Australia.
Wong LH; Murdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, VIC, 3052, Australia.
Nguyen LK; Novo Nordisk Foundation Center for Stem Cell Medicine, Murdoch Children's Research Institute, Melbourne, VIC, 3052, Australia.
Papa A; Department of Clinical Pathology, University of Melbourne, Melbourne, VIC, Australia.

NPJ Precis Oncol ; 8(1): 20, 2024 Jan 26.

Article em En | MEDLINE | ID: mdl-38273040

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: NPJ Precis Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google